Antibodies News and Research

RSS

Musica Humana: Innovative program highlights inspiring role of music in human thought and memory

According to renowned neurologist Oliver Sacks, "music can move us to the heights or depths of emotion, but the power of music goes much further."

9 Dec 2016

ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients

ABIVAX an innovative biotechnology company targeting the immune system to eliminate viral disease, announced today that the Company presented new preclinical data on ABX464, ABIVAX's first-in-class drug candidate for a functional cure of patients with HIV/AIDS, during this week's HIV DART scientific conference in Los Cabos, Mexico.

9 Dec 2016

Research shows alternative strategy to administer antibody-based immunotherapy for bladder cancer

Antibody-based immunotherapy is a new promising method to treat cancer. Unfortunately, today's treatments can result in adverse side effects.

8 Dec 2016

Researchers discover first toxin antitoxin system in biofilms

Bacterial resistance does not come just through adaptation to antibiotics, sometimes the bacteria simply go to sleep.

8 Dec 2016

Empa researchers developing solution to magnetically remove bacteria from blood

Blood poisoning is still fatal in more than 50% of cases, but can be cured if treated at an early stage. The highest priority is therefore to act quickly.

8 Dec 2016

Scientists find novel way for earlier detection of deadly Merkel cell carcinoma

Scientists have found a way to detect earlier if a deadly cancer, Merkel cell carcinoma (MCC), is recurring in patients, according to a paper to be published 11 a.m. Eastern time, Dec. 7, in the journal Cancer.

7 Dec 2016

Study shows involvement of lipid metabolism in tumour metastasis

A study headed by Salvador Aznar Benitah, ICREA researcher at the Institute for Research in Biomedicine, and published today in Nature identifies metastasis-initiating cells through a specific marker, namely the protein CD36.

7 Dec 2016

Detecting inflammation in diabetic patients

As well as presenting with high blood glucose, diabetic patients have chronic low-grade inflammation, which can be measured by a range of inflammatory markers such as so-called high-sensitive CRP, TNFa and IL-6 as well as a full blood cell count.

7 Dec 2016

New UTMB study sheds light on how Ebola effectively disables immune system

A new study at The University of Texas Medical Branch in Galveston sheds light on how Ebola so effectively disables the human immune system.

6 Dec 2016

Researchers find strong link between angiotensin receptor autoantibodies and increased risk of frailty

Results of a new study led by Johns Hopkins researchers offer new evidence for a strong link between angiotensin receptor autoantibodies and increased risk of frailty.

6 Dec 2016

Research validates effectiveness of world-first dental vaccine

A world-first vaccine developed by Melbourne scientists, which could eliminate or at least reduce the need for surgery and antibiotics for severe gum disease, has been validated by research published this weekend in a leading international journal.

5 Dec 2016

Study reveals new way to improve stability of common protein drugs

Gaining access to important biopharmaceuticals needed to treat illnesses and autoimmune diseases is one of the biggest obstacles developing countries face.

2 Dec 2016

Novel imaging agent can rapidly and accurately detect metastasis of prostate cancer

New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of prostate cancer, even in areas where detection has previously been difficult.

2 Dec 2016

Study suggests new approach to treat white blood cells of sepsis patients

New research findings published in the Journal of Leukocyte Biology, suggest that treating the white blood cells of sepsis patients with antibodies that block programmed cell death-1 (PD-1) and programmed cell death ligand (PD-L1) molecules may restore their function and ultimately their ability to eradicate deadly bacteria.

1 Dec 2016

Duke researchers modify popular drug-delivery technology to evade immune responses

Biomedical engineers at Duke University have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials.

1 Dec 2016

Treatment with biosimilar drug improves progression-free survival in breast cancer patients

Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to a study published online by JAMA.

1 Dec 2016

Novel imaging technique shows promise to detect, monitor and guide therapy for prostate cancer

An international group of researchers report success in mice of a method of using positron emission tomography scans to track, in real time, an antibody targeting a hormone receptor pathway specifically involved in prostate cancer.

1 Dec 2016

FDG PET-CT imaging helps assess anatomical structure and metabolic activity in patients with GLILD

A new proof of concept study has shown that an imaging technique more commonly used to assess cancer patients may also be of help in assessing disease and treatment effects in patients with inflammatory diseases.

30 Nov 2016

Study finds 1 in 5 pediatric celiac disease patients on gluten-free diet sustain persistent intestinal damage

In surprising findings, researchers from MassGeneral Hospital for Children and Boston Children's Hospital have discovered that nearly one in five children with celiac disease sustained persistent intestinal damage, despite strict adherence to a gluten-free diet.

30 Nov 2016

Researchers develop new way to design glycoclusters for targeted drug delivery

A team led by researchers at the RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan has developed a way to engineer glycan complexes--clusters of sugar chains attached to proteins or lipids--in a way that allows the molecules to be transported preferentially to specific organs of the body, depending on the sugar chains contained in the cluster.

29 Nov 2016

Antibodies News and Research

Musica Humana: Innovative program highlights inspiring role of music in human thought and memory

ABIVAX reports preclinical data on first-in-class drug candidate for functional cure of HIV/AIDS patients

Research shows alternative strategy to administer antibody-based immunotherapy for bladder cancer

Researchers discover first toxin antitoxin system in biofilms

Empa researchers developing solution to magnetically remove bacteria from blood

Scientists find novel way for earlier detection of deadly Merkel cell carcinoma

Study shows involvement of lipid metabolism in tumour metastasis

Detecting inflammation in diabetic patients

New UTMB study sheds light on how Ebola effectively disables immune system

Researchers find strong link between angiotensin receptor autoantibodies and increased risk of frailty

Research validates effectiveness of world-first dental vaccine

Study reveals new way to improve stability of common protein drugs

Novel imaging agent can rapidly and accurately detect metastasis of prostate cancer

Study suggests new approach to treat white blood cells of sepsis patients

Duke researchers modify popular drug-delivery technology to evade immune responses

Treatment with biosimilar drug improves progression-free survival in breast cancer patients

Novel imaging technique shows promise to detect, monitor and guide therapy for prostate cancer

FDG PET-CT imaging helps assess anatomical structure and metabolic activity in patients with GLILD

Study finds 1 in 5 pediatric celiac disease patients on gluten-free diet sustain persistent intestinal damage

Researchers develop new way to design glycoclusters for targeted drug delivery

eBook: End-to-end solutions for bispecific antibody development eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo